| Date Filed | Type | Description |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 12,042 shares
@ $1.6, valued at
$19.3k
|
|
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 11,820 shares
@ $1.63, valued at
$19.3k
|
|
| 07/03/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 13,380 shares
@ $1.44, valued at
$19.3k
|
|
| 06/16/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 13,196 shares
@ $1.46, valued at
$19.3k
|
|
| 06/01/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 12,272 shares
@ $1.57, valued at
$19.3k
|
|
| 05/16/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 11,748 shares
@ $1.64, valued at
$19.3k
|
|
| 05/09/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 10,947 shares
@ $1.76, valued at
$19.3k
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 9,175 shares
@ $2.1, valued at
$19.3k
|
|
| 03/16/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 10,140 shares
@ $1.9, valued at
$19.3k
|
|
| 03/02/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 9,308 shares
@ $2.07, valued at
$19.3k
Paid exercise price by delivering 75,529 shares
@ $2.07, valued at
$156.3k
|
|
| 02/07/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 143,836 shares
@ $1.43, valued at
$205.7k
|
|
| 01/31/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 15,086 shares
@ $1.16, valued at
$17.5k
|
|
| 01/30/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 70,000 options to buy
@ $1.11, valued at
$77.7k
|
|
| 01/17/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 15,351 shares
@ $1.14, valued at
$17.5k
|
|
| 01/03/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 15,487 shares
@ $1.13, valued at
$17.5k
|
|
| 12/15/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 15,086 shares
@ $1.16, valued at
$17.5k
|
|
| 12/01/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 13,780 shares
@ $1.27, valued at
$17.5k
|
|
| 11/15/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 14,113 shares
@ $1.24, valued at
$17.5k
|
|
| 10/17/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 10,802 shares
@ $1.62, valued at
$17.5k
|
|
| 10/03/2022 |
4/A
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 10,736 shares
@ $1.63, valued at
$17.5k
|
|
| 10/03/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 10,736 shares
@ $1.79, valued at
$19.2k
|
|
| 09/15/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 9,777 shares
@ $1.79, valued at
$17.5k
|
|
| 09/01/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 9,211 shares
@ $1.9, valued at
$17.5k
|
|
| 08/15/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 8,028 shares
@ $2.18, valued at
$17.5k
|
|
| 08/01/2022 |
4/A
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 7,743 shares
@ $2.26, valued at
$17.5k
|
|
| 08/01/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 10,606 shares
@ $2.26, valued at
$24k
|
|
| 07/18/2022 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 10,606 shares
@ $1.65, valued at
$17.5k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|